Trial Search
Current Search Criteria:
Biologics in Management of Inflammatory Bowel Disease in Egyptian Patients
N/AInflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcera...
Status
Completed
Location
Faculty of pharmacy-Helwan University
Start Date
2021-07-15
Trial ID
NCT05720221
A Direct Head-to-head Comparison of Ustekinumab with Infliximab for the Treatment of Ulcerative Colitis
N/Athe goal of this study is to compare the efficacy of ustekinumab with infli...
Status
Not Yet Recruiting
Location
El-Demerdash hospital
Start Date
2025-05-15
Trial ID
NCT06786507
Treatments Being Tested
A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease
PHASE2This study is open to adults, aged 18-75 years, with moderate to severe Cro...
Status
Terminated
Location
California Medical Research Associates Inc.
Start Date
2021-12-02
Trial ID
NCT04978493
Treatments Being Tested
A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease
PHASE2The purpose of this study is to examine the safety and efficacy of CNTO 127...
Status
Completed
Location
Multiple Locations
Start Date
2004-04
Trial ID
NCT00265122
Treatments Being Tested
The Clinical Efficacy and Influence Factors of Individualized Treatment of Ustekinumab in Crohn's Disease
N/AThe loss of response rate of ustekinumab(UST) is high, and the specific mec...
Status
Completed
Location
The Second Affiliated Hospital of Wenzhou Medical University
Start Date
2020-07-01
Trial ID
NCT06785493
Treatments Being Tested
Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease
N/AThis study intends to select patients with confirmed moderate-to-severe Cro...
Status
Recruiting
Location
Department of Gastroenterology, Seventh Medical Center of PLA Army General Hospital
Start Date
2024-08-01
Trial ID
NCT05387031
Treatments Being Tested
A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
PHASE1The purpose of this study is to evaluate the pharmacokinetic (PK) (blood le...
Status
Completed
Location
Multiple Locations
Start Date
2014-05
Trial ID
NCT02156375
Treatments Being Tested
Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease
N/AThis study intends to select patients with confirmed moderate-to-severe Cro...
Status
Recruiting
Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2026-03-01
Trial ID
NCT07444060
Treatments Being Tested
Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions
PHASE4Using transcriptomics and proteomics to gain insights in the development of...
Status
Completed
Location
UZ Leuven
Start Date
2019-01-22
Trial ID
NCT03629379
Treatments Being Tested
An Early Access Program For Ustekinumab In Participants With Moderately To Severely Active Crohn's Disease
N/AThe purpose of this program is to provide early access to ustekinumab where...
Status
No Longer Available
Location
Hospital Nossa Senhora Das Gracas
Start Date
TBD
Trial ID
NCT03362736
Treatments Being Tested